Gonadotroph Tumors Show Subtype Differences that Might Have Implications for Therapy

SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors

(2020) Solène Castellnou et al.   Endocrine Connections

Emerging and Novel Treatments for Pituitary Tumors

(2019) Ilie et al.   Journal of Clinical Medicine

A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal

(2019) C. Villa et al.   VIRCHOWS ARCHIV

The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications

(2019) Mirela Diana Ilie et al.   Cancers

Pangenomic Classification of Pituitary Neuroendocrine Tumors

(2019) Mario Neou et al.   CANCER CELL

Updates in the Medical Treatment of Pituitary Adenomas

(2019) Monica Livia Gheorghiu et al.   HORMONE AND METABOLIC RESEARCH

COMPARISON OF CABERGOLINE VERSUS RALOXIFENE ADD-ON THERAPY TO LONG-ACTING SOMATOSTATIN ANALOGUE IN PATIENTS WITH INADEQUATELY CONTROLLED ACROMEGALY: A RANDOMIZED OPEN LABEL CLINICAL TRIAL

(2018) Mehrnaz Imani et al.   Endocrine Practice

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

(2018) Ann McCormack et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

CLINICAL AND PATHOLOGICAL ASPECTS OF SILENT PITUITARY ADENOMAS

(2018) Juliana Drummond et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Management of NFAs: medical treatment

(2018) Naomi Even-Zohar et al.   Pituitary

Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma

(2018) Rafael L. Batista et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

(2017) S L Asa et al.   ENDOCRINE-RELATED CANCER

Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA

(2017) Kristin Astrid Øystese et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prognostic factors of regrowth in nonfunctioning pituitary tumors

(2017) Gerald Raverot et al.   Pituitary

Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists

(2016) Y Greenman et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas andin vivoresponse to cabergoline therapy

(2015) Leonardo Vieira Neto et al.   CLINICAL ENDOCRINOLOGY

The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas

(2015) Hiroshi Nishioka et al.   ENDOCRINE PATHOLOGY

Ocena efektów leczenia analogami somatostatyny nieczynnych hormonalnie gruczolaków przysadki w porównaniu z akromegalią

(2015) Natalia Bożena Zawada et al.   Endokrynologia Polska

Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth

(2015) E. Delgrange et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary

(2014) Misu Lee et al.   ENDOCRINE-RELATED CANCER

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

(2013) Jacqueline Trouillas et al.   ACTA NEUROPATHOLOGICA

Short-term treatment with cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas

(2012) Erica C. Garcia et al.   Pituitary

Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case–control study

(2011) Alessandra Fusco et al.   Pituitary

Co-expression of somatostatin receptor subtypes and estrogen receptor-α mRNAs by non-functioning pituitary adenomas in young patients

(2010) Hiroshi Nishioka et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Medical therapy for clinically non-functioning pituitary adenomas

(2008) A. Colao et al.   ENDOCRINE-RELATED CANCER